What community measurements can be used to predict bone disease in patients with COPD?

Respiratory Medicine

Volumn 102, Issue 5, 2008, Pages 651-657

  Bolton, C E ^a   Cannings John, R ^b   Edwards, P H ^c   Ionescu, A A ^a   Evans, W D ^d   Pettit, R J ^d   Faulkner, T A ^c   Stone, M D ^a   Shale, D J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^c Ely Bridge Surgery   (United Kingdom)

^d UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Anthropometry; Body composition; COPD; Osteoporosis

Indexed keywords

CORTICOSTEROID DERIVATIVE;

AGED; ANTHROPOMETRY; ARTICLE; BODY MASS; BODY WEIGHT; BONE DENSITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL ASSESSMENT; OSTEOPOROSIS; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SPIROMETRY;

ABSORPTIOMETRY, PHOTON; AGED; BODY MASS INDEX; BODY WEIGHT; BONE DENSITY; FEMALE; FOREARM; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; ROC CURVE; SKINFOLD THICKNESS; SPIROMETRY;

EID: 41349120783     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.12.027     Document Type: Article

References (35)

1. Schols A.M., Broekhuizen R., Weling-Scheepers C.A., and Wouters E.F. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 82 1 (2005) 53-59
2. Bernard S., LeBlanc P., Whittom F., Carrier G., Jobin J., Belleau R., et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 158 (1998) 629-634
3. Bolton C.E., Ionescu A.A., Shiels K., et al. Associated loss of fat free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 170 (2004) 1286-1293
4. Bolton C.E., Evans M., Ionescu A.A., et al. Insulin resistance and inflammation-a further systemic complication of COPD. Chronic Obstruct Pulm Dis 4 2 (2007) 121-126
5. Sabit R., Bolton C.E., Edwards P.H., et al. Arterial stiffness and osteoporosis in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 175 (2007) 1259-1265
6. Jacobsen S.J., Goldberg J., Miles T.P., Brody J.A., Stiers W., and Rimm A.A. Race and sex differences in mortality following fracture of the hip. Am J Public Health 82 (1992) 1147-1150
7. Jørgensen N.R., Schwarz P., Holme I., Henriksen B.M., Petersen L.J., and Backer V. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. Respir Med 101 1 (2007) 177-185
8. Blake G.M., Wahner H.W., and Fogelman I. The evaluation of osteoporosis: dual energy X-ray absorptiometry and ultrasound in clinical practice (1998), Martin Dunitz, London
9. Chronic Obstructive Pulmonary Disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 59 Suppl 1 (2004) 1-232
10. Celli B.R., MacNee W., and Committee members. Standards for the diagnosis treatment of patients with COPD: a summary of the ATS/ERS position paper American thoracic society/European respiratory society (ATS/ERS). Eur Respir J 23 (2004) 932-946
11. Global Initiative for chronic Obstructive Pulmonary Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO workshop report, 2001 〈http://www.goldcopd.com〉.
12. HMSO. Nutrition and health in old age (1979), HMSO, London
13. VanItallie T.B., Yang M.U., Heymsfield S.B., Funk R.C., and Boileau R.A. Height-normalised indices of the body's fat-free mass and fat mass: potentially useful indicators of nutritional status. Am J Clin Nutr 52 (1990) 953-959
14. Grant J.P., Custer P.B., and Thurlow J. Current techniques of nutritional assessment. Surg Clin North Am 61 (1981) 437-463
15. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group (1994), WHO, Geneva [Technical report series 843]
16. Hosmer D.W., and Lemeshow S. Applied logistic regression (1989), Wiley, New York
17. Weinstein M.C., and Fineberg H.V. Clinical decision analysis (1980), WB Saunders, Philadelphia
18. Leech J.A., Dullberg C., Kellie S., Pattee L., and Gay J. Relationship of lung function to severity of osteoporosis in women. Am Rev Respir Dis 141 (1990) 68-71
19. Engelen M.P.K.J., Schols A.M.W.J., Heidendal G.A.K., and Wouters E.F.M. Dual-energy X-ray absorptiometry in the clinical evaluation of body composition and bone mineral density in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 68 (1998) 1298-1303
20. Iqbal F., Michaelson J., Thaler L., Rubin J., Roman J., and Nanes M.S. Declining bone mass in men with chronic pulmonary disease. Chest 116 (1999) 1616-1624
21. McEvoy C.E., Ensrud K.E., Bender E., Genant H.K., Yu W., Griffith J.M., et al. Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157 (1998) 704-709
22. Papaioannou A., Parkinson W., Ferko N., et al. Prevalence of vertebral fractures among patients with chronic obstructive pulmonary disease in Canada. Osteoporosis Int 14 (2003) 913-917
23. Incalzi R.A., Caradonna P., Ranieri P., et al. Correlates of osteoporosis in chronic obstructive pulmonary disease. Respir Med 94 (2000) 1079-1084
24. Steiner M.C., Barton R.L., Singh S.J., and Morgan M.D. Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. Eur Respir J 19 4 (2002) 626-631
25. Celli B.R., Cote C.G., Marin J.M., et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350 10 (2004) 1005-1012
26. Landbo C., Prescott E., Lange P., Vestbo J., and Almdal T.P. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160 6 (1999) 1856-1861
27. Scottish Intercollegiate Guidelines Network. Management of Osteoporosis. A national clinical guideline. June 2003 〈www.sign.ac.uk〉.
28. Manolagas S.C., and Jilka R.L. Bone Marrow, cytokines and bone remodelling. N Engl J Med 332 (1995) 305-311
29. Amin S., Zhang Y., Felson D.T., et al. Estradiol, testosterone, and the risk for hip fractures in elderly men from the Framingham Study. Am J Med 119 (2006) 426-433
30. Dubois E.F., Röder E., Dekhuijzen P.N., Zwinderman A.E., and Schweitzer D.H. Dual energy X-ray absorptiometry outcomes in male COPD patients after treatments with different glucocorticoid regimens. Chest 121 (2002) 1456-1463
31. Marshall D., Johnell O., and Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. Br Med J 312 7041 (1996) 1254-1259
32. Scottish Intercollegiate Guideline Network. 2003. Management of Osteoporosis. Guideline 71. ISBN1899893733. 〈www.sign.ac.uk/guidelines/fulltext/71/index.html〉.
33. Nguyen N.D., Pongchaiyakul C., Center J.R., Eisman J.A., and Nguyen T.V. Identification of high-risk individuals for hip fracture: a 14-year prospective study. J Bone Miner Res 20 11 (2005) 1921-1928
34. GMS contract 2003. Investing in clinical practice. The NHS confederation, British Medical Association. 〈http://www.bma.org.uk/ap.nsf/Content/NewGMSContract〉.
35. RCP. The royal college of physicians. Glucocorticoid-induced osteoporosis: guidelines for prevention and treatment, 2003.